BARD1 and Alzheimer disease: Principally, our data show that the lower DSB levels in the AD PS1 P117L-mutated cells, compared to the SH-SY5Y cells, cannot be explained by the Tip60/Fe65 pathway but rather by the activation of the BRCA1/BARD1 pathway.